Please enable JavaScript in your web browser to get the best experience.

Using pooled CRISPR screening to drive oncology drug discovery

The Joint AstraZeneca - Cancer Research Horizons Functional Genomics Centre: Using pooled CRISPR screening to drive oncology drug discovery

TechNets-Nikhil Gupta-webinar — Principal Scientist at Functional Genomics Centre (FGC), Nikhil Gupta, discusses how the FGC is leading the development and improvement of genetic screening tools, with the goal of accelerating the discovery of new cancer medicines.